STOCK TITAN

[424B3] Beneficient Prospectus Filed Pursuant to Rule 424(b)(3)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
424B3
Rhea-AI Filing Summary

Beneficient (Nasdaq: BENF) filed Prospectus Supplement No. 16 to update its November 12, 2024 S-1 prospectus with information from a Form 8-K filed on June 25, 2025. The update principally discloses the June 17, 2025 closing of a $1.91 million Series B-8 primary capital transaction conducted through a subsidiary.

Under the agreement, Beneficient’s trust vehicles acquired a limited-partner interest in an investment fund with a net asset value of $1,910,370. In exchange, the customer received 191,037 shares of Series B-8 Resettable Convertible Preferred Stock, each with a $0.001 par value. The preferred shares were issued under Section 4(a)(2) and Regulation D and therefore were not registered under the Securities Act.

The Series B-8 Preferred Stock:

  • Initial conversion price: $0.3397 per Class A share, subject to monthly resets but not below 75 % of the initial price and with a floor of $0.2548.
  • Maximum share issuance upon conversion: 7,497,528 Class A shares.
  • Automatic conversion on the earlier of (i) five years after issuance if reporting or registration conditions are met, or (ii) the first date Rule 144 sales or an effective resale registration become available, all subject to 4.99 % beneficial-ownership and Nasdaq exchange-cap limitations.
  • Ranking: pari passu with Class A common; junior to the company’s Series A and Series B-1 through B-7 preferred series.

The company remains an emerging growth and controlled company under Nasdaq rules. As of June 24, 2025, BENF closed at $0.2770; BENFW warrants closed at $0.0069.

Beneficient (Nasdaq: BENF) ha depositato il Supplemento al Prospetto n. 16 per aggiornare il prospetto S-1 del 12 novembre 2024 con informazioni provenienti da un modulo 8-K presentato il 25 giugno 2025. L'aggiornamento comunica principalmente la chiusura, avvenuta il 17 giugno 2025, di una operazione primaria di capitale Serie B-8 da 1,91 milioni di dollari effettuata tramite una controllata.

Secondo l'accordo, i veicoli fiduciari di Beneficient hanno acquisito una quota da socio accomandatario in un fondo di investimento con un valore patrimoniale netto di 1.910.370 dollari. In cambio, il cliente ha ricevuto 191.037 azioni di Serie B-8 Resettable Convertible Preferred Stock, ciascuna con un valore nominale di 0,001 dollari. Le azioni privilegiate sono state emesse ai sensi della Sezione 4(a)(2) e del Regolamento D e pertanto non sono state registrate ai sensi del Securities Act.

Le azioni privilegiate Serie B-8 prevedono:

  • Prezzo di conversione iniziale: 0,3397 dollari per azione Classe A, soggetto a reset mensili ma non inferiore al 75% del prezzo iniziale e con un minimo di 0,2548 dollari.
  • Massimo numero di azioni emesse in conversione: 7.497.528 azioni Classe A.
  • Conversione automatica al primo tra (i) cinque anni dopo l'emissione se sono soddisfatte le condizioni di reporting o registrazione, oppure (ii) la prima data in cui sono disponibili vendite secondo la Regola 144 o una registrazione efficace per la rivendita, il tutto soggetto a limiti di possesso effettivo del 4,99% e restrizioni della borsa Nasdaq.
  • Classifica: pari passu con le azioni ordinarie Classe A; subordinato alle serie di azioni privilegiate Serie A e Serie B-1 fino a B-7 dell’azienda.

L’azienda rimane una società in crescita emergente e controllata secondo le regole Nasdaq. Al 24 giugno 2025, il titolo BENF ha chiuso a 0,2770 dollari; i warrant BENFW hanno chiuso a 0,0069 dollari.

Beneficient (Nasdaq: BENF) presentó el Suplemento al Prospecto No. 16 para actualizar su prospecto S-1 del 12 de noviembre de 2024 con información de un Formulario 8-K presentado el 25 de junio de 2025. La actualización revela principalmente el cierre, el 17 de junio de 2025, de una transacción primaria de capital Serie B-8 por 1,91 millones de dólares realizada a través de una subsidiaria.

Bajo el acuerdo, los vehículos fiduciarios de Beneficient adquirieron una participación limitada en un fondo de inversión con un valor neto de activos de 1.910.370 dólares. A cambio, el cliente recibió 191.037 acciones Serie B-8 Resettable Convertible Preferred Stock, cada una con un valor nominal de 0,001 dólares. Las acciones preferentes se emitieron conforme a la Sección 4(a)(2) y el Reglamento D, por lo que no están registradas bajo la Ley de Valores.

Las acciones preferentes Serie B-8 incluyen:

  • Precio inicial de conversión: 0,3397 dólares por acción Clase A, sujeto a reajustes mensuales pero no por debajo del 75 % del precio inicial y con un piso de 0,2548 dólares.
  • Emisión máxima de acciones tras conversión: 7.497.528 acciones Clase A.
  • Conversión automática en la primera de (i) cinco años después de la emisión si se cumplen las condiciones de reporte o registro, o (ii) la primera fecha en que estén disponibles ventas bajo la Regla 144 o un registro efectivo para reventa, todo sujeto a límites de propiedad beneficiosa del 4,99 % y restricciones del Nasdaq.
  • Clasificación: igual que las acciones comunes Clase A; subordinadas a las series preferentes Serie A y Serie B-1 a B-7 de la empresa.

La compañía sigue siendo una empresa emergente y controlada según las reglas del Nasdaq. Al 24 de junio de 2025, BENF cerró en 0,2770 dólares; los warrants BENFW cerraron en 0,0069 dólares.

Beneficient (나스닥: BENF)는 2024년 11월 12일 S-1 증권신고서에 대한 보충서 제16호를 제출하여 2025년 6월 25일 제출된 Form 8-K의 정보를 업데이트했습니다. 이번 업데이트는 주로 2025년 6월 17일 자회사를 통해 진행된 191만 달러 규모의 B-8 시리즈 주요 자본 거래의 마감을 공개합니다.

계약에 따라 Beneficient의 신탁 차량들은 순자산 가치가 1,910,370달러인 투자 펀드의 유한책임사원 지분을 취득했습니다. 그 대가로 고객은 각 액면가 0.001달러인 191,037주의 B-8 시리즈 리셋 가능 전환 우선주를 받았습니다. 이 우선주는 섹션 4(a)(2) 및 규정 D에 따라 발행되어 증권법에 따라 등록되지 않았습니다.

B-8 시리즈 우선주의 조건은 다음과 같습니다:

  • 초기 전환 가격: 클래스 A 주당 0.3397달러, 매월 리셋되지만 초기 가격의 75% 이하로는 내려가지 않으며 최저가 0.2548달러가 적용됩니다.
  • 전환 시 최대 발행 주식 수: 7,497,528주 클래스 A 주식.
  • 자동 전환 조건: (i) 발행 후 5년 경과 시 보고 또는 등록 조건 충족 시, 또는 (ii) Rule 144에 따른 매도 가능일 또는 효과적인 재판매 등록일 중 빠른 날, 단 4.99%의 실질 소유 한도 및 나스닥 거래소 제한 조건 적용.
  • 순위: 클래스 A 보통주와 동등하며, 회사의 시리즈 A 및 B-1부터 B-7까지 우선주보다 하위.

회사는 나스닥 규정에 따라 여전히 신흥 성장 및 통제 회사로 분류됩니다. 2025년 6월 24일 기준 BENF 주가는 0.2770달러로 마감했으며, BENFW 워런트는 0.0069달러에 마감했습니다.

Beneficient (Nasdaq : BENF) a déposé le Supplément au Prospectus n°16 pour mettre à jour son prospectus S-1 du 12 novembre 2024 avec des informations issues d’un formulaire 8-K déposé le 25 juin 2025. Cette mise à jour révèle principalement la clôture, le 17 juin 2025, d’une transaction de capital primaire de Série B-8 d’un montant de 1,91 million de dollars réalisée par l’intermédiaire d’une filiale.

Dans le cadre de l’accord, les véhicules fiduciaires de Beneficient ont acquis une participation de commandité dans un fonds d’investissement dont la valeur nette d’actifs s’élève à 1 910 370 dollars. En échange, le client a reçu 191 037 actions de Série B-8 Resettable Convertible Preferred Stock, chacune ayant une valeur nominale de 0,001 dollar. Les actions privilégiées ont été émises en vertu de la Section 4(a)(2) et du Règlement D et ne sont donc pas enregistrées en vertu du Securities Act.

Les actions privilégiées de Série B-8 présentent les caractéristiques suivantes :

  • Prix de conversion initial : 0,3397 dollar par action de Classe A, soumis à des réinitialisations mensuelles mais ne pouvant pas descendre en dessous de 75 % du prix initial, avec un plancher fixé à 0,2548 dollar.
  • Nombre maximal d’actions émises lors de la conversion : 7 497 528 actions de Classe A.
  • Conversion automatique à la première échéance entre (i) cinq ans après l’émission si les conditions de déclaration ou d’enregistrement sont remplies, ou (ii) la première date à laquelle les ventes selon la Règle 144 ou un enregistrement effectif de revente deviennent disponibles, sous réserve des limites de détention effective de 4,99 % et des restrictions de la bourse Nasdaq.
  • Classement : au même rang que les actions ordinaires de Classe A ; subordonné aux séries d’actions privilégiées Série A et Série B-1 à B-7 de la société.

La société reste une entreprise émergente et contrôlée selon les règles du Nasdaq. Au 24 juin 2025, le cours de clôture de BENF était de 0,2770 dollar ; les bons de souscription BENFW ont clôturé à 0,0069 dollar.

Beneficient (Nasdaq: BENF) hat den Nachtrag Nr. 16 zum Verkaufsprospekt eingereicht, um seinen S-1-Prospekt vom 12. November 2024 mit Informationen aus einem am 25. Juni 2025 eingereichten Formular 8-K zu aktualisieren. Das Update gibt hauptsächlich den Abschluss einer 1,91 Millionen US-Dollar schweren Serie B-8 Primärkapitaltransaktion am 17. Juni 2025 über eine Tochtergesellschaft bekannt.

Im Rahmen der Vereinbarung erwarben die Treuhandvehikel von Beneficient eine Kommanditbeteiligung an einem Investmentfonds mit einem Nettovermögenswert von 1.910.370 US-Dollar. Im Gegenzug erhielt der Kunde 191.037 Aktien der Serie B-8 Resettable Convertible Preferred Stock, jeweils mit einem Nennwert von 0,001 US-Dollar. Die Vorzugsaktien wurden gemäß Abschnitt 4(a)(2) und Regulation D ausgegeben und sind daher nicht gemäß dem Securities Act registriert.

Die Serie B-8 Vorzugsaktien umfassen:

  • Ursprünglicher Wandlungspreis: 0,3397 US-Dollar pro Klasse-A-Aktie, monatlich anpassbar, jedoch nicht unter 75 % des Anfangspreises und mit einem Mindestpreis von 0,2548 US-Dollar.
  • Maximale Aktienausgabe bei Wandlung: 7.497.528 Klasse-A-Aktien.
  • Automatische Wandlung bei dem früheren der beiden Zeitpunkte (i) fünf Jahre nach Ausgabe, sofern Melde- oder Registrierungsbedingungen erfüllt sind, oder (ii) dem ersten Datum, an dem Verkäufe nach Regel 144 oder eine wirksame Wiederverkaufsregistrierung möglich sind, jeweils vorbehaltlich einer 4,99 %igen wirtschaftlichen Eigentumsgrenze und Nasdaq-Börsenbeschränkungen.
  • Rang: pari passu mit Klasse-A-Stammaktien; nachrangig gegenüber den Vorzugsaktien der Serien A sowie B-1 bis B-7 des Unternehmens.

Das Unternehmen bleibt gemäß den Nasdaq-Regeln ein wachsendes und kontrolliertes Unternehmen. Zum 24. Juni 2025 schloss BENF bei 0,2770 US-Dollar; die BENFW-Warrants schlossen bei 0,0069 US-Dollar.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small $1.9 m preferred-for-asset swap adds AUM, but resets could create up to 7.5 m new shares, holding neutral overall impact.

The transaction boosts Beneficient’s assets by acquiring a fund LP interest worth $1.91 million without using cash, consistent with the firm’s business model of exchanging alternative-asset stakes for securities. However, the Series B-8 preferred carries a low initial conversion price of $0.3397—just 23 % above the June 24 close—plus a monthly reset mechanism that can push the price down to a $0.2548 floor. If fully converted, dilution could reach roughly 7.5 million shares, equal to about 3.7 % of the 203.2 million Class A shares covered by the prospectus. Because the deal is modest relative to the share base and no cash leaves the company, the net financial impact appears limited. I therefore view the disclosure as neutral for valuation near term.

TL;DR: Resettable preferred terms heighten dilution and governance concerns; minor immediate effect but structurally negative.

The B-8 certificate of designation introduces a reset feature that revises conversion pricing to the trailing five-day VWAP each month, capped only by a 25 % downside band. Such mechanics incentivize downward price pressure and enhance dilution risk, particularly given BENF’s low trading price and controlled-company status. Although the 4.99 % holder cap and Nasdaq exchange cap provide some guardrails, the potential issuance of 7.5 million new shares at deep discounts is shareholder-unfriendly. Moreover, mandatory conversion up to five years out could align with periods of market weakness, compounding dilution. From a governance perspective, continued reliance on unregistered, privately negotiated preferred instruments under Section 4(a)(2) underscores limited external scrutiny. Collectively these factors skew the disclosure negative for minority shareholders.

Beneficient (Nasdaq: BENF) ha depositato il Supplemento al Prospetto n. 16 per aggiornare il prospetto S-1 del 12 novembre 2024 con informazioni provenienti da un modulo 8-K presentato il 25 giugno 2025. L'aggiornamento comunica principalmente la chiusura, avvenuta il 17 giugno 2025, di una operazione primaria di capitale Serie B-8 da 1,91 milioni di dollari effettuata tramite una controllata.

Secondo l'accordo, i veicoli fiduciari di Beneficient hanno acquisito una quota da socio accomandatario in un fondo di investimento con un valore patrimoniale netto di 1.910.370 dollari. In cambio, il cliente ha ricevuto 191.037 azioni di Serie B-8 Resettable Convertible Preferred Stock, ciascuna con un valore nominale di 0,001 dollari. Le azioni privilegiate sono state emesse ai sensi della Sezione 4(a)(2) e del Regolamento D e pertanto non sono state registrate ai sensi del Securities Act.

Le azioni privilegiate Serie B-8 prevedono:

  • Prezzo di conversione iniziale: 0,3397 dollari per azione Classe A, soggetto a reset mensili ma non inferiore al 75% del prezzo iniziale e con un minimo di 0,2548 dollari.
  • Massimo numero di azioni emesse in conversione: 7.497.528 azioni Classe A.
  • Conversione automatica al primo tra (i) cinque anni dopo l'emissione se sono soddisfatte le condizioni di reporting o registrazione, oppure (ii) la prima data in cui sono disponibili vendite secondo la Regola 144 o una registrazione efficace per la rivendita, il tutto soggetto a limiti di possesso effettivo del 4,99% e restrizioni della borsa Nasdaq.
  • Classifica: pari passu con le azioni ordinarie Classe A; subordinato alle serie di azioni privilegiate Serie A e Serie B-1 fino a B-7 dell’azienda.

L’azienda rimane una società in crescita emergente e controllata secondo le regole Nasdaq. Al 24 giugno 2025, il titolo BENF ha chiuso a 0,2770 dollari; i warrant BENFW hanno chiuso a 0,0069 dollari.

Beneficient (Nasdaq: BENF) presentó el Suplemento al Prospecto No. 16 para actualizar su prospecto S-1 del 12 de noviembre de 2024 con información de un Formulario 8-K presentado el 25 de junio de 2025. La actualización revela principalmente el cierre, el 17 de junio de 2025, de una transacción primaria de capital Serie B-8 por 1,91 millones de dólares realizada a través de una subsidiaria.

Bajo el acuerdo, los vehículos fiduciarios de Beneficient adquirieron una participación limitada en un fondo de inversión con un valor neto de activos de 1.910.370 dólares. A cambio, el cliente recibió 191.037 acciones Serie B-8 Resettable Convertible Preferred Stock, cada una con un valor nominal de 0,001 dólares. Las acciones preferentes se emitieron conforme a la Sección 4(a)(2) y el Reglamento D, por lo que no están registradas bajo la Ley de Valores.

Las acciones preferentes Serie B-8 incluyen:

  • Precio inicial de conversión: 0,3397 dólares por acción Clase A, sujeto a reajustes mensuales pero no por debajo del 75 % del precio inicial y con un piso de 0,2548 dólares.
  • Emisión máxima de acciones tras conversión: 7.497.528 acciones Clase A.
  • Conversión automática en la primera de (i) cinco años después de la emisión si se cumplen las condiciones de reporte o registro, o (ii) la primera fecha en que estén disponibles ventas bajo la Regla 144 o un registro efectivo para reventa, todo sujeto a límites de propiedad beneficiosa del 4,99 % y restricciones del Nasdaq.
  • Clasificación: igual que las acciones comunes Clase A; subordinadas a las series preferentes Serie A y Serie B-1 a B-7 de la empresa.

La compañía sigue siendo una empresa emergente y controlada según las reglas del Nasdaq. Al 24 de junio de 2025, BENF cerró en 0,2770 dólares; los warrants BENFW cerraron en 0,0069 dólares.

Beneficient (나스닥: BENF)는 2024년 11월 12일 S-1 증권신고서에 대한 보충서 제16호를 제출하여 2025년 6월 25일 제출된 Form 8-K의 정보를 업데이트했습니다. 이번 업데이트는 주로 2025년 6월 17일 자회사를 통해 진행된 191만 달러 규모의 B-8 시리즈 주요 자본 거래의 마감을 공개합니다.

계약에 따라 Beneficient의 신탁 차량들은 순자산 가치가 1,910,370달러인 투자 펀드의 유한책임사원 지분을 취득했습니다. 그 대가로 고객은 각 액면가 0.001달러인 191,037주의 B-8 시리즈 리셋 가능 전환 우선주를 받았습니다. 이 우선주는 섹션 4(a)(2) 및 규정 D에 따라 발행되어 증권법에 따라 등록되지 않았습니다.

B-8 시리즈 우선주의 조건은 다음과 같습니다:

  • 초기 전환 가격: 클래스 A 주당 0.3397달러, 매월 리셋되지만 초기 가격의 75% 이하로는 내려가지 않으며 최저가 0.2548달러가 적용됩니다.
  • 전환 시 최대 발행 주식 수: 7,497,528주 클래스 A 주식.
  • 자동 전환 조건: (i) 발행 후 5년 경과 시 보고 또는 등록 조건 충족 시, 또는 (ii) Rule 144에 따른 매도 가능일 또는 효과적인 재판매 등록일 중 빠른 날, 단 4.99%의 실질 소유 한도 및 나스닥 거래소 제한 조건 적용.
  • 순위: 클래스 A 보통주와 동등하며, 회사의 시리즈 A 및 B-1부터 B-7까지 우선주보다 하위.

회사는 나스닥 규정에 따라 여전히 신흥 성장 및 통제 회사로 분류됩니다. 2025년 6월 24일 기준 BENF 주가는 0.2770달러로 마감했으며, BENFW 워런트는 0.0069달러에 마감했습니다.

Beneficient (Nasdaq : BENF) a déposé le Supplément au Prospectus n°16 pour mettre à jour son prospectus S-1 du 12 novembre 2024 avec des informations issues d’un formulaire 8-K déposé le 25 juin 2025. Cette mise à jour révèle principalement la clôture, le 17 juin 2025, d’une transaction de capital primaire de Série B-8 d’un montant de 1,91 million de dollars réalisée par l’intermédiaire d’une filiale.

Dans le cadre de l’accord, les véhicules fiduciaires de Beneficient ont acquis une participation de commandité dans un fonds d’investissement dont la valeur nette d’actifs s’élève à 1 910 370 dollars. En échange, le client a reçu 191 037 actions de Série B-8 Resettable Convertible Preferred Stock, chacune ayant une valeur nominale de 0,001 dollar. Les actions privilégiées ont été émises en vertu de la Section 4(a)(2) et du Règlement D et ne sont donc pas enregistrées en vertu du Securities Act.

Les actions privilégiées de Série B-8 présentent les caractéristiques suivantes :

  • Prix de conversion initial : 0,3397 dollar par action de Classe A, soumis à des réinitialisations mensuelles mais ne pouvant pas descendre en dessous de 75 % du prix initial, avec un plancher fixé à 0,2548 dollar.
  • Nombre maximal d’actions émises lors de la conversion : 7 497 528 actions de Classe A.
  • Conversion automatique à la première échéance entre (i) cinq ans après l’émission si les conditions de déclaration ou d’enregistrement sont remplies, ou (ii) la première date à laquelle les ventes selon la Règle 144 ou un enregistrement effectif de revente deviennent disponibles, sous réserve des limites de détention effective de 4,99 % et des restrictions de la bourse Nasdaq.
  • Classement : au même rang que les actions ordinaires de Classe A ; subordonné aux séries d’actions privilégiées Série A et Série B-1 à B-7 de la société.

La société reste une entreprise émergente et contrôlée selon les règles du Nasdaq. Au 24 juin 2025, le cours de clôture de BENF était de 0,2770 dollar ; les bons de souscription BENFW ont clôturé à 0,0069 dollar.

Beneficient (Nasdaq: BENF) hat den Nachtrag Nr. 16 zum Verkaufsprospekt eingereicht, um seinen S-1-Prospekt vom 12. November 2024 mit Informationen aus einem am 25. Juni 2025 eingereichten Formular 8-K zu aktualisieren. Das Update gibt hauptsächlich den Abschluss einer 1,91 Millionen US-Dollar schweren Serie B-8 Primärkapitaltransaktion am 17. Juni 2025 über eine Tochtergesellschaft bekannt.

Im Rahmen der Vereinbarung erwarben die Treuhandvehikel von Beneficient eine Kommanditbeteiligung an einem Investmentfonds mit einem Nettovermögenswert von 1.910.370 US-Dollar. Im Gegenzug erhielt der Kunde 191.037 Aktien der Serie B-8 Resettable Convertible Preferred Stock, jeweils mit einem Nennwert von 0,001 US-Dollar. Die Vorzugsaktien wurden gemäß Abschnitt 4(a)(2) und Regulation D ausgegeben und sind daher nicht gemäß dem Securities Act registriert.

Die Serie B-8 Vorzugsaktien umfassen:

  • Ursprünglicher Wandlungspreis: 0,3397 US-Dollar pro Klasse-A-Aktie, monatlich anpassbar, jedoch nicht unter 75 % des Anfangspreises und mit einem Mindestpreis von 0,2548 US-Dollar.
  • Maximale Aktienausgabe bei Wandlung: 7.497.528 Klasse-A-Aktien.
  • Automatische Wandlung bei dem früheren der beiden Zeitpunkte (i) fünf Jahre nach Ausgabe, sofern Melde- oder Registrierungsbedingungen erfüllt sind, oder (ii) dem ersten Datum, an dem Verkäufe nach Regel 144 oder eine wirksame Wiederverkaufsregistrierung möglich sind, jeweils vorbehaltlich einer 4,99 %igen wirtschaftlichen Eigentumsgrenze und Nasdaq-Börsenbeschränkungen.
  • Rang: pari passu mit Klasse-A-Stammaktien; nachrangig gegenüber den Vorzugsaktien der Serien A sowie B-1 bis B-7 des Unternehmens.

Das Unternehmen bleibt gemäß den Nasdaq-Regeln ein wachsendes und kontrolliertes Unternehmen. Zum 24. Juni 2025 schloss BENF bei 0,2770 US-Dollar; die BENFW-Warrants schlossen bei 0,0069 US-Dollar.

 

Prospectus Supplement No. 16

(to Prospectus dated November 12, 2024)

 

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-281694

 

BENEFICIENT

203,212,927 Shares of Class A Common Stock

 

 

 

This prospectus supplement updates and supplements the prospectus of Beneficient, a Nevada corporation (the “Company,” “we,” “us” or “our”), dated November 12, 2024, which forms a part of our Registration Statement on Form S-1, as amended (Registration No. 333-281694) (the “Prospectus”). This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Current Report on Form 8-K, filed with the Securities and Exchange Commission (the “SEC”) on June 25, 2025. Accordingly, we have attached the Form 8-K to this prospectus supplement. The information included in the Form 8-K that is furnished shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

 

This prospectus supplement should be read in conjunction with the Prospectus. This prospectus supplement updates and supplements the information in the Prospectus. If there is any inconsistency between the information in the Prospectuses and this prospectus supplement, you should rely on the information in this prospectus supplement.

 

Our Class A common stock, par value $0.001 per share (the “Class A common stock”), is listed on The Nasdaq Capital Market under the symbol “BENF,” and the warrants, with each warrant exercisable for one share of Class A common stock and one share of Series A preferred stock, par value $0.001 per share, at an exercise price of $11.50 (the “Warrants”), are listed on The Nasdaq Capital Market under the symbol “BENFW”. On June 24, 2025, the last reported sales price of the Class A common stock was $0.2770 per share, and the last reported sales price of our Warrants was $0.0069 per Warrant. We are an “emerging growth company” and a “smaller reporting company” as defined under the U.S. federal securities laws and, as such, may elect to comply with certain reduced public company reporting requirements for this and future filings. Certain holders of our Class B common stock, par value $0.001 per share (the “Class B common stock”), have entered into a stockholders agreement concerning the election of directors of the Company, and holders of Class B common stock have the right to elect a majority of the Company’s directors. As a result, the Company is a “controlled company” within the meaning of the Nasdaq Listing Rules and may elect not to comply with certain corporate governance standards.

 

 

 

Investing in our securities involves risk. See the sections entitled “Risk Factors” beginning on page 9 of the Prospectus and under similar headings in any further amendments or supplements to the Prospectus to read about factors you should consider before buying our securities.

 

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if any Prospectus or this prospectus supplement is truthful or complete. Any representation to the contrary is a criminal offense.

 

 

 

The date of this prospectus supplement is June 25, 2025.

 

 

 

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 17, 2025

 

 

 

Beneficient

(Exact Name of Registrant as Specified in Charter)

 

 

 

Nevada   001-41715   72-1573705

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

325 North St. Paul Street, Suite 4850

Dallas, Texas 75201

(Address of Principal Executive Offices, and Zip Code)

 

(214) 445-4700

Registrant’s Telephone Number, Including Area Code

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Shares of Class A common stock, par value $0.001 per share   BENF   Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Class A common stock, par value $0.001 per share, and one share of Series A convertible preferred stock, par value $0.001 per share   BENFW   Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 3.02 Unregistered Sales of Equity Securities.

 

Series B-8 Primary Capital Transaction

 

On June 17, 2025, Beneficient, a Nevada corporation (the “Company”), through one of its subsidiaries, closed a primary capital transaction for which an agreement was entered on May 22, 2025 with a customer with respect to a limited partner interest in an investment fund with a net asset value of $1,910,370 (the “Transaction”). Pursuant to the Transaction, the Company’s customized trust vehicles acquired a limited partner interest, and in exchange for such, the customer received 191,037 shares of the Company’s Series B-8 Resettable Convertible Preferred Stock, par value $0.001 per share (the “Series B-8 Preferred Stock”), with such Series B-8 Preferred Stock being convertible into shares of the Company’s Class A Common Stock, par value $0.001 per share (the “Class A Common Stock”).

 

The issuance of the Series B-8 Preferred Stock pursuant to the Transaction was not registered under the Securities Act of 1933, as amended (the “Securities Act”), and was issued in reliance upon the exemption provided in Section 4(a)(2) of the Securities Act and Regulation D promulgated thereunder.

 

The Series B-8 Preferred Stock is convertible into Class A Common Stock initially at a conversion price of $0.3397 per share (the “B-8 Conversion Price”). The B-8 Conversion Price is subject to reset from time to time and a floor price of $0.2548 per share. A maximum of 7,497,528 shares of Class A Common Stock may be issued upon conversion of the Series B-8 Preferred Stock. The information in Item 5.03 concerning the material terms of the Series B-8 Preferred Stock is incorporated by reference herein.

 

Item 3.03 Material Modifications to Rights of Security Holders.

 

The disclosure required by this Item 3.03 is included in Item 5.03 of this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

Series B-8 Preferred Stock

 

On June 17, 2025, the Company filed a certificate of designation (the “B-8 Certificate of Designation”) with the Secretary of State of Nevada, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the shares of the Series B-8 Preferred Stock. The material terms of the Series B-8 Preferred Stock are described below. The total number of authorized shares of the Series B-8 Preferred Stock is 191,037 shares.

 

Optional Conversion

 

Each share of Series B-8 Preferred Stock is convertible, at the option of the holder thereof upon two business days’ written notice to the Company, into a number of shares of Class A Common Stock that is equal to $10.00 divided by the B-8 Conversion Price in effect as of the date of such notice (the “B-8 Conversion Rate”). The B-8 Conversion Price shall be subject to reset on each date (each such date, a “B-8 Reset Date”) that is the last day of each month following the date of issuance of the Series B-8 Preferred Stock (the “B-8 Original Issue Date”). On each B-8 Reset Date, the B-8 Conversion Price shall be increased or decreased to the five day trailing volume weighted average price of the Class A Common Stock on the Nasdaq Capital Market or such other national securities exchange on which the Class A Common Stock is listed for trading as of the applicable B-8 Reset Date as reported by Bloomberg Financial Markets or an equivalent reporting service as determined by the Company (the “Prevailing Market Price”), provided that in no event shall the reset B-8 Conversion Price be (a) less than 75% of the initial B-8 Conversion Price or (b) higher than the initial B-8 Conversion Price, in each case subject to adjustments for stock dividends, splits or combinations, reorganizations, recapitalizations or similar transactions. As further described in the B-8 Certificate of Designation, the Company will not issue any shares of Class A Common Stock upon conversion of any Series B-8 Preferred Stock if the issuance of such shares of Class A Common Stock would exceed the Exchange Cap (as defined below), except that such limitation shall not apply in the event that the Company obtains the approval of its stockholders as required by the applicable rules and regulations of The Nasdaq Stock Market, LLC (“Nasdaq”) for issuances of shares of Class A Common Stock in excess of the Exchange Cap.

 

 

 

 

Mandatory Conversion

 

Each outstanding share of Series B-8 Preferred Stock will automatically convert into a number of shares of Class A Common Stock (the “B-8 Mandatory Conversion”) as is determined by the B-8 Conversion Rate then in effect on the date (the “B-8 Mandatory Conversion Date”) that is the earliest to occur of: (a) the last day of the month in which the fifth anniversary of the B-8 Original Issue Date occurs, if either the Company has filed all annual reports on Form 10-K and quarterly reports on Form 10-Q that are then required to have been filed in the preceding twelve months with the United States Securities and Exchange Commission (the “SEC”) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or a resale registration statement with respect to the shares of Class A Common Stock underlying the Series B-8 Preferred Stock (the “B-8 Resale Registration Statement”) has become effective and is in full force and effect at the time of such B-8 Mandatory Conversion and (b) if the conditions of clause (a) are not met on the date that is the last day of the month in which the fifth anniversary of the B-8 Original Issue Date occurs, the first date thereafter on which any shares of Series B-8 Preferred Stock may be resold pursuant to Rule 144 under the Securities Act, or the B-8 Resale Registration Statement has become effective. Notwithstanding the foregoing, the Series B-8 Preferred Stock shall not convert into Class A Common Stock to the extent such conversion would cause a holder to exceed (i) 4.99% (the “B-8 Beneficial Ownership Limitation”) of the number of shares of the Class A Common Stock outstanding immediately after giving effect to the issuance of shares of Class A Common Stock issuable upon conversion of Series B-8 Preferred Stock held by the applicable holder or (ii) the aggregate number of shares of Class A Common Stock that the Company may issue upon conversion of the Series B-8 Preferred Stock without breaching the Company’s obligations under the rules and regulations of Nasdaq (the number of shares which may be issued without violating such rules and regulations, the “Exchange Cap”). To the extent a conversion would cause a holder to exceed the B-8 Beneficial Ownership Limitation or Exchange Cap, as applicable, the conversion of the portion of such conversion that would exceed the B-8 Beneficial Ownership Limitation or Exchange Cap, as applicable, shall be delayed until the first day the conversion of such portion would not cause the holder to exceed the B-8 Beneficial Ownership Limitation or, with respect to the Exchange Cap, when stockholder approval as required by the applicable rules and regulations of Nasdaq has been obtained. Further, to the extent any such share of Series B-8 Preferred Stock has not otherwise automatically converted into shares of Class A Common Stock, the B-8 Conversion Price for such shares shall be subject to additional resets on the terms described in the B-8 Certificate of Designation on the last date of each month.

 

Ranking

 

Series B-8 Preferred Stock will, with respect to dividend rights and rights upon liquidation, dissolution or winding up of the Company, rank: (a) pari passu to the Class A Common Stock; (b) junior with respect to the Company’s Series A Convertible Preferred Stock, par value $0.001 per share, Series B-1 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-2 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-3 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-4 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-5 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-6 Resettable Convertible Preferred Stock, par value $0.001 per share and Series B-7 Resettable Convertible Preferred Stock, par value $0.001 per share; (c) senior, pari passu or junior with respect to any other series of preferred stock, as set forth in the Certificate of Designation with respect to such preferred stock; and (d) junior to all existing and future indebtedness of the Company.

 

Liquidation Preference

 

In the event of any liquidation or dissolution of the Company, the holders of Series B-8 Preferred Stock shall be entitled receive, pro rata with the holders of the Company’s Class A Common Stock, and any other shares of preferred stock of the Company identified as “Designated Preferred Stock,” a per share amount equal to such amount per share as would have been payable had all shares of Series B-8 Preferred Stock been converted to Class A Common Stock pursuant to Section 8 of the B-8 Certificate of Designation (without giving effect to any ownership limitations therein) immediately prior to such liquidation or dissolution of the Company (the “Liquidation Preference”). The Series B-8 Preferred Stock shall be a series of Designated Preferred Stock.

 

 

 

 

Dividends

 

Dividends will be paid on the Series B-8 Preferred Stock on an as-converted basis when, as, and if paid on the Class A Common Stock.

 

Voting Rights

 

Except as required by law, the holders of Series B-8 Preferred Stock shall not be entitled to vote at any meeting of the stockholders for election of members of the Board of Directors of the Company or for any other purpose or otherwise to participate in any action taken by the Company or the stockholders thereof, or to receive notice of any meeting of stockholders.

 

The foregoing summary of the B-8 Certificate of Designation does not purport to be complete and is subject to, and qualified in its entirety by, such document, which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Item 7.01 Regulation FD Disclosure.

 

On June 24, 2025, the Company issued a press release announcing the closing of the Transaction.

 

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

 

The information in this Item 7.01 (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act, or otherwise subject to liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act, except as expressly set forth in such filing.

 

Item 9.01 Exhibits and Financial Statements.

 

(d) Exhibits.

 

Exhibit

No.

  Description of Exhibit
   
3.1   Certificate of Designation of Series B-8 Resettable Convertible Preferred Stock.
   
99.1   Press Release issued by Beneficient on June 24, 2025.
     
104   Cover Page Interactive Data File (formatted as Inline XBRL).

 

Cautionary Note Regarding Forward-Looking Statements

 

Except for the historical information contained herein, the matters set forth in this Current Report on Form 8-K are forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this Current Report include, without limitation, statements related to the Transaction and the issuance of Class A Common Stock upon conversion of the Series B-8 Preferred Stock. These and other forward-looking statements are based on management’s current views and assumptions and involve risks and uncertainties that could significantly affect expected results. Important factors that could cause actual results to differ materially from those expressed in the forward-looking statements include, among other things, the risks, uncertainties, and factors set forth under “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and its subsequently filed Quarterly Reports on Form 10-Q. Forward-looking statements speak only as of the date they are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events, or circumstances or other changes affecting such statements except to the extent required by applicable law.

 

 

 

 

Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.

 

Important Information and Where You Can Find It

 

This Current Report on Form 8-K may be deemed to be solicitation material in respect of a vote of stockholders to approve the issuance of Class A Common Stock upon conversion of the Series B-8 Preferred Stock. In connection with the requisite stockholder approval, the Company will file with the SEC a preliminary proxy statement and a definitive proxy statement, which will be sent to the stockholders of the Company, seeking such approvals related to the issuance of Class A Common Stock upon conversion of the Series B-8 Preferred Stock.

 

INVESTORS AND SECURITY HOLDERS OF THE COMPANY AND THEIR RESPECTIVE AFFILIATES ARE URGED TO READ, WHEN AVAILABLE, THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE TRANSACTION DESCRIBED HEREIN, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE TRANSACTION. Investors and security holders will be able to obtain a free copy of the proxy statement, as well as other relevant documents filed with the SEC containing information about the Company, without charge, at the SEC’s website (http://www.sec.gov). Copies of documents filed with the SEC by the Company can also be obtained, without charge, by directing a request to Investor Relations, Beneficient at 325 North St. Paul Street, Suite 4850, Dallas, Texas 75201 or email investors@beneficient.com.

 

Participants in the Solicitation of Proxies in Connection with Transaction

 

The Company and certain of its directors, executive officers and employees may be deemed to be participants in the solicitation of proxies in respect of the requisite stockholder approvals under the rules of the SEC. Information regarding the Company’s directors and executive officers is available in its Annual Report on Form 10-K, which was filed with the SEC on July 9, 2024, and certain current reports on Form 8-K filed by the Company. Other information regarding the participants in the solicitation of proxies with respect to the transaction described herein and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the proxy statement and other relevant materials to be filed with the SEC. Free copies of these documents, when available, may be obtained as described in the preceding paragraph.

 

Not an Offer of Securities

 

The information in this Current Report on Form 8-K is for informational purposes only and shall not constitute, or form a part of, an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities. The securities that are the subject of the transaction described herein have not been registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BENEFICIENT
     
  By:

/s/ Gregory W. Ezell

  Name:  Gregory W. Ezell
  Title: Chief Financial Officer
     
  Dated: June 25, 2025

 

 

 

 

Exhibit 3.1

 

 

 

 

 

CERTIFICATE OF DESIGNATION OF

 

SERIES B-8 RESETTABLE CONVERTIBLE PREFERRED STOCK OF

 

BENEFICIENT

 

(Pursuant to NRS 78.1955)

 

Beneficient, a corporation organized and existing under the laws of the State of Nevada (the “Corporation”), does hereby certify that, pursuant to the authority conferred on its board of directors (the “Board of Directors”) by its articles of incorporation (the “Articles of Incorporation”) and in accordance with Section 78.1955 of the Nevada Revised Statutes, the Board of Directors adopted the following resolution establishing a series of 191,037 shares of Preferred Stock of the Corporation designated as Series B-8 Resettable Convertible Preferred Stock.

 

BE IT RESOLVED, that pursuant to the authority conferred on the Board of Directors of this Corporation by the Articles of Incorporation, a series of Preferred Stock, $0.001 par value, of the Corporation be and hereby is established and created, and that the designation and number of shares thereof and the voting and other powers, preferences and relative, participating, optional or other rights of the shares of such series and the qualifications, limitations and restrictions thereof are as follows:

 

1.Designation and Number. A series of Preferred Stock, designated as Series B-8 Resettable Convertible Preferred Stock (“Series B-8 Preferred Stock”), is hereby established. The number of authorized shares of Series B-8 Preferred Stock shall initially be 191,037 shares.

 

2.No Sinking Fund. There shall be no sinking fund for the payment of dividends or liquidation preferences on Series B-8 Preferred Stock or the redemption of any shares thereof.

 

3.Rank. Series B-8 Preferred Stock will, with respect to dividend rights and rights upon liquidation, dissolution or winding up of the Corporation, rank: (a) pari passu to the Corporation’s common stock; (b) junior with respect to the Corporation’s Series A Convertible Preferred Stock, par value $0.001 per share, Series B-1 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-2 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-3 Resettable Convertible Preferred Stock, Series B-4 Resettable Convertible Preferred Stock, par value $0.001 per share; Series B-5 Resettable Convertible Preferred Stock, par value $0.001 per share, Series B-6 Resettable Convertible Preferred Stock, par value $0.001 per share, and Series B-7 Resettable Convertible Preferred Stock, par value $0.001 per share (c) senior, pari passu or junior with respect to any other series of preferred stock, as set forth in the Certificate of Designation with respect to such preferred stock; and (d) junior to all existing and future indebtedness of the Corporation.

 

4.Liquidation Preference. In the event of any liquidation or dissolution of the Corporation, the holders of Series B-8 Preferred Stock shall be entitled receive, pro rata with the holders of the Common Stock, and any other shares of preferred stock of the Corporation identified as “Designated Preferred Stock,” a per share amount equal to such amount per share as would have been payable had all shares of Series B-8 Preferred Stock been converted to Common Stock pursuant to Section 8 (without giving effect to the limitations in Sections 8.4 or 10) immediately prior to such liquidation or dissolution of the Corporation (the “Liquidation Preference”). The Series B-8 Preferred Stock shall be a series of Designated Preferred Stock.

 

 

 

 

4.1.Adjustment. For purposes of this Section 4, in the event that the shares of Series B-8 Preferred Stock have not been converted into shares of the Corporation’s Class A Common Stock, par value $0.001 per share (“Class A Common Stock”), and in the event that the Corporation either: (a) subdivides (by stock split, reclassification or otherwise) the outstanding shares of Series B-8 Preferred Stock into a greater number of shares of Series B-8 Preferred Stock; or (b) combines or consolidates (by reverse stock split) the outstanding shares of Series B-8 Preferred Stock into a smaller number of shares of Series B-8 Preferred Stock, then the Liquidation Preference shall be proportionately decreased or increased, as appropriate, simultaneously with the occurrence of such event.

 

4.2.Consolidation or Merger of the Corporation. The consolidation or merger of the Corporation with or into any other corporation, trust or entity or of any other corporation, trust or entity with or into the Corporation, or the sale, lease, exchange offer, tender offer or any other transfer, or conveyance of all or substantially all of the property or business of the Corporation, shall not be deemed to constitute a liquidation, dissolution or winding up of the Corporation.

 

4.3.No Further Rights. After payment of the full amount of the Liquidation Preference, the holders of Series B-8 Preferred Stock will have no right or claim to any of the remaining assets of the Corporation by virtue of their ownership of Series B-8 Preferred Stock.

 

5.No Voting Rights. Except as required by law, the holders of Series B-8 Preferred Stock shall not be entitled to vote at any meeting of the stockholders for election of members of the Board of Directors of the Corporation or for any other purpose or otherwise to participate in any action taken by the Corporation or the stockholders thereof, or to receive notice of any meeting of stockholders.

 

6.Dividend Rights. Dividends will be paid on the Series B-8 Preferred Stock on an as-converted basis when, as, and if paid on the Class A Common Stock.

 

7.Redemption. The outstanding shares of Series B-8 Preferred Stock shall not be redeemable by the Corporation.

 

8.Optional Conversion. Each share of Series B-8 Preferred Stock is convertible, at the option of the holder thereof upon two business days’ written notice to the Corporation, into a number of shares of Class A Common Stock that is equal to the Stated Value divided by the Conversion Price (as defined below) in effect as of the date of such notice (the “Conversion Rate”). The Conversion Price shall be subject to reset on each date (each such date, a “Reset Date”) that is the last day of each month following the date of issuance of the Series B-8 Preferred Stock (the “Original Issue Date”). On each Reset Date, the Conversion Price shall be increased or decreased to the Prevailing Market Price (as defined below), provided that in no event shall the reset Conversion Price be (a) less than 75% of the initial Conversion Price or (b) higher than the initial Conversion Price, in each case subject to adjustments for stock dividends, splits or combinations, reorganizations, recapitalizations or similar transactions.

 

8.1.As used herein, the term “Stated Value” shall mean $10.00 per share of Series B-8 Preferred Stock.

 

8.2.As used herein, the term “Conversion Price” shall initially mean $0.3397 per share.

 

8.3.As used herein, the term “Prevailing Market Price” shall mean the five day trailing volume weighted average price of the Class A Common Stock on the Nasdaq Capital Market or such other national securities exchange on which the Class A Common Stock is listed for trading (“Nasdaq”) as of the applicable Reset Date as reported by Bloomberg Financial Markets or an equivalent reporting service as determined by the Corporation.

 

 

 

 

8.4.Principal Market Regulation. The Corporation shall not issue any shares of Class A Common Stock upon conversion of any Series B-8 Preferred Stock or otherwise pursuant to the terms of this Certificate of Designation if the issuance of such shares of Class A Common Stock would exceed the aggregate number of shares of Class A Common Stock that the Corporation may issue upon conversion of the Series B-8 Preferred Stock without breaching the Corporation’s obligations under the rules and regulations of Nasdaq (the number of shares which may be issued without violating such rules and regulations, the “Exchange Cap”), except that such limitation shall not apply in the event that the Corporation obtains the approval of its stockholders as required by the applicable rules and regulations of Nasdaq for issuances of shares of Class A Common Stock in excess of the Exchange Cap. Until such approval is obtained, shares of Series B-8 Preferred Stock shall not convert into Class A Common Stock to the extent such conversion would cause the Corporation to issue shares of Class A Common Stock in excess of the Exchange Cap; provided that the conversion of the portion of such conversion that would not exceed the Exchange Cap shall not be delayed pursuant to this Section 8; provided, further that, the conversion of the portion of such conversion that would exceed the Exchange Cap shall be delayed until the first day the conversion of such portion would not cause the Corporation to exceed the Exchange Cap. Further, to the extent any such share of Series B-8 Preferred Stock has not otherwise automatically converted into shares of Class A Common Stock pursuant to Section 9, the Conversion Price for such shares shall be subject to additional resets on the terms described in Section 8 hereof on the last date of each month.

 

9.Mandatory Conversion. Each outstanding share of Series B-8 Preferred Stock will automatically convert into a number of shares of Class A Common Stock (the “Mandatory Conversion”) as is determined by the Conversion Rate then in effect on the date (the “Mandatory Conversion Date”) that is the earliest to occur of: (a) the last day of the month in which the fifth anniversary of the Original Issue Date occurs, if either the Corporation has filed all annual reports on Form 10-K and quarterly reports on Form 10-Q that are then required to have been filed in the preceding twelve months with the United States Securities and Exchange Commission (the “SEC”) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or a resale registration statement with respect to the shares of Class A Common Stock underlying the Series B-8 Preferred Stock (the “Resale Registration Statement”) has become effective and is in full force and effect at the time of such Mandatory Conversion and (b) if the conditions of clause (a) are not met on the date that is the last day of the month in which the fifth anniversary of the Original Issue Date occurs, the first date thereafter on which any shares of Series B-8 Preferred Stock may be resold pursuant to Rule 144 under the Securities Act of 1933, as amended, or the Resale Registration Statement has become effective. Notwithstanding the foregoing, the Series B-8 Preferred Stock shall not convert into Class A Common Stock to the extent such conversion would cause a holder to exceed the Beneficial Ownership Limitation (as defined below) under Section 10 or the Exchange Cap under Section 8.4 hereof and to the extent a conversion would cause a holder to exceed the Beneficial Ownership Limitation or Exchange Cap, as applicable, the conversion of the portion of such conversion that would exceed the Beneficial Ownership Limitation or Exchange Cap, as applicable, shall be delayed until the first day the conversion of such portion would not cause the holder to exceed the Beneficial Ownership Limitation or, with respect to the Exchange Cap, when stockholder approval has been obtained. Further, to the extent any such share of Series B-8 Preferred Stock has not otherwise automatically converted into shares of Class A Common Stock pursuant to this Section 9, the Conversion Price for such shares shall be subject to additional resets on the terms described in Section 8 hereof on the last date of each month.

 

10.Beneficial Ownership Limitation. The Corporation shall not effect any conversion of the Series B-8 Preferred Stock, including, without limitation, a Mandatory Conversion, and a holder of the Series B-8 Preferred Stock shall not have the right to receive dividends hereunder or convert any portion of the Series B-8 Preferred Stock, to the extent that, after giving effect to such a conversion, such holder would (together with such holder’s affiliates and any persons acting as a group together with such holder or any of such holder’s affiliates (such persons, “Attribution Parties”)) own in excess of the Beneficial Ownership Limitation. For purposes of the foregoing sentence, the number of shares of Class A Common Stock beneficially owned by such holder and its affiliates and Attribution Parties shall include the number of shares of Class A Common Stock received as shares pursuant to a dividend or issuable upon conversion of the Series B-8 Preferred Stock with respect to which such determination is being made, but shall exclude the number of shares of Class A Common Stock which are issuable upon (a) conversion of the remaining, unconverted Series B-8 Preferred Stock beneficially owned by such holder or any of its affiliates or Attribution Parties and (b) exercise or conversion of the unexercised or unconverted portion of any other securities of the Corporation subject to a limitation on conversion or exercise analogous to the limitation contained herein (including, without limitation, the Series B-8 Preferred Stock) beneficially owned by such holder or any of its affiliates or Attribution Parties. Except as set forth in the preceding sentence, for purposes of this Section 10, beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged by the holder that the Corporation is not representing to the holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the holder is solely responsible for any schedules required to be filed in accordance therewith (other than as it relates to a holder relying on the number of shares issued and outstanding as provided by the Corporation pursuant to this Section 10). In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 10, in determining the number of outstanding shares of Class A Common Stock, a holder may rely on the number of outstanding shares of Class A Common Stock as stated in the most recent of the following: (i) the Corporation’s most recent periodic or annual report filed with the SEC, as the case may be, (ii) a more recent public announcement by the Corporation or (iii) a more recent written notice by the Corporation or the Corporation’s transfer agent setting forth the number of shares of Class A Common Stock outstanding.

 

 

 

 

10.1.As used herein, the term “Beneficial Ownership Limitation” shall initially mean 4.99% of the number of shares of the Class A Common Stock outstanding immediately after giving effect to the issuance of shares of Class A Common Stock issuable upon conversion of Series B-8 Preferred Stock held by the applicable holder. A holder, upon at least sixty-one (61) days advance notice to the Corporation, may terminate, waive, increase or decrease the Beneficial Ownership Limitation provisions of this Section 10. Notwithstanding the foregoing, without Stockholder Approval, the Beneficial Ownership Limitation shall not exceed the Cap.

 

11.No Fractional Shares. The Corporation shall not issue any fractional shares of Class A Common Stock upon conversion of shares of Series B-8 Preferred Stock. If the conversion would result in the issuance of a fraction of a share of Class A Common Stock, the Corporation shall round such fraction of a share of Class A Common Stock up to the nearest whole share.

 

12.Adjustment for Reclassification, Exchange, and Substitution. If at any time or from time to time after the Original Issue Date, the shares of Class A Common Stock issuable upon the conversion of the Series B-8 Preferred Stock shall be changed into the same or a different number of shares of any class or classes of stock, whether by recapitalization, reclassification, reorganization, merger, exchange, consolidation, sale of assets or otherwise (other than by a Class A Common Stock Event (as defined below) or a stock dividend or distribution provided for elsewhere in this Certificate of Designation), then, in any such event, the Series B-8 Preferred Stock shall thereafter convert into the kind and amount of stock and other securities and property receivable upon such recapitalization, reclassification, reorganization, merger, exchange, consolidation, sale of assets or other change by a holder of the number of shares of Class A Common Stock into which such shares of Series B-8 Preferred Stock would have been converted immediately prior to such recapitalization, reclassification, reorganization, merger, exchange, consolidation, sale of assets or other change, all subject to further adjustment as provided herein or with respect to such other securities or property by the terms thereof.

 

13.Adjustment Upon Class A Common Stock Event. In the event that a Class A Common Stock Event occurs at any time or from time to time after the Original Issue Date, the Conversion Price in effect immediately prior to such event shall, simultaneously with the occurrence of such Class A Common Stock Event, be proportionately decreased or increased, as appropriate. The Conversion Price shall be readjusted in the same manner upon the happening of each subsequent Class A Common Stock Event.

 

13.1.Class A Common Stock Event. As used herein, the term “Class A Common Stock Event” means: (1) the declaration or payment of any dividend or other distribution on the Class A Common Stock, without consideration, payable to one or more stockholders in additional shares of Class A Common Stock or other securities or rights convertible into, or entitling the holder thereof to receive, directly or indirectly, additional shares of Class A Common Stock; (2) a subdivision (by stock split, reclassification or otherwise) of the outstanding shares of Class A Common Stock into a greater number of shares of Class A Common Stock; or (3) a combination or consolidation (by reverse stock split) of the outstanding shares of Class A Common Stock into a smaller number of shares of Class A Common Stock.

 

14.Transfer Restrictions. The shares of Series B-8 Preferred Stock may not be sold, assigned or otherwise transferred without the written consent of the Corporation. Any such sale, assignment or transfer shall be void ab initio and of no effect. For avoidance of doubt, this Section 14 shall not apply to shares of Class A Common Stock issued upon conversion of the Series B-8 Preferred Stock.

 

15.Notice. Except as may otherwise be provided for herein, all notices referred to herein shall be in writing, and all notices hereunder shall be deemed to have been given upon the earlier of receipt of such notice or four business days after the mailing of such notice, if sent by registered mail, with postage pre-paid, addressed: (a) if to the Corporation, to the attention of its corporate secretary or to an agent of the Corporation designated as permitted by the Corporation’s Articles of Incorporation, as amended; (b) if to any holder of Series B-8 Preferred Stock, to such holder at the address of such holder as listed in the stock record books of the Corporation (which may include the records of the Corporation’s transfer agent); or (c) to such other address as the Corporation or holder, as the case may be, shall have designated by notice similarly given.

 

 

 

FAQ

What did Beneficient (BENF) announce in Prospectus Supplement No. 16?

It updated its S-1 to include a June 17, 2025 Form 8-K detailing issuance of Series B-8 preferred stock for a $1.91 m asset acquisition.

How many Series B-8 preferred shares were issued and what is the potential dilution?

191,037 shares were issued, convertible into up to 7,497,528 Class A common shares.

What is the initial conversion price for the Series B-8 preferred stock?

The initial conversion price is $0.3397 per Class A share, with a floor of $0.2548.

When will the Series B-8 preferred shares automatically convert?

They convert on the earliest of five years after issuance (subject to SEC filing or registration conditions) or the first date Rule 144 resale or an effective registration is available.

Where are Beneficient’s securities traded and what were the last closing prices?

Class A common trades on Nasdaq as BENF (last price $0.2770 on 24 Jun 2025); warrants trade as BENFW (last price $0.0069).
Beneficient-A

NASDAQ:BENF

BENF Rankings

BENF Latest News

BENF Latest SEC Filings

BENF Stock Data

2.60M
7.14M
13.76%
12.8%
1.26%
Asset Management
Finance Services
Link
United States
DALLAS